April 30, 2020

Oncology practice group Florida Cancer Specialists & Research Institute LLC entered into a deferred prosecution agreement admitting to a criminal antitrust conspiracy in the form of an agreement with another provider not to compete to provide chemotherapy and radiation treatments to cancer patients in southwest Florida.  FCS will pay a $100 million criminal penalty and cooperate with ongoing federal antitrust investigations into market allocation and other anticompetitive conduct in the oncology industry.  DOJ

Tagged in: Financial and Investment Fraud, Healthcare Fraud, Provider Fraud,